STRIBILD (elvitegravir/cobicistat) Patient Assistance Program
Don’t let the high cost of brand single-tablet HIV regimens disrupt your treatment. We help eligible patients access Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate, EVG/c/FTC/TDF) is a once-daily, single-tablet HIV-1 regimen FDA-approved for treatment-naïve adults and pediatric patients ≥35 kg, and for virologically suppressed adults switching from another regimen.
- Without assistance, Stribild costs commonly run approximately $3,300–$3,800 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Stribild for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Stribild in the U.S. as of 2026 (elvitegravir/cobicistat is still patent-protected). Genvoya (the same regimen with TAF instead of TDF — less kidney and bone toxicity) is widely used as a reformulation. HIV guidelines now generally prefer Biktarvy or dolutegravir-based regimens for new starts.
What Is Stribild Prescription Assistance Program?
The Stribild Prescription Assistance Program is a manufacturer-sponsored initiative that provides Stribild at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV treatment patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Stribild costs roughly $3,300–$3,800/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$3,700.00 | Save ~$3,630/mo |
| CVS Pharmacy | ~$3,800.00 | Save ~$3,730/mo |
| Walmart | ~$3,400.00 | Save ~$3,330/mo |
| Costco | ~$3,350.00 | Save ~$3,280/mo |
Kroger | ~$3,400.00 | Save ~$3,330/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Stribild Prescription Program?
The Patient Assistance Program is free to apply for and provides Stribild at no medication cost if approved. Our $69.95/month service covers full advocacy. With Genvoya (TAF reformulation) and Biktarvy now available, your provider may have already considered switching — we can help coordinate.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Stribild:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,300–$3,800 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Stribild assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Stribild Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Stribild:
Stribild (EVG/c/FTC/TDF) is a once-daily, single-tablet, four-drug HIV-1 regimen. It combines the integrase strand transfer inhibitor elvitegravir, the booster cobicistat, and the NRTIs emtricitabine and tenofovir disoproxil fumarate (TDF).
How Stribild Works:
Stribild combines three active antiviral agents to block HIV replication by targeting the integration and reverse transcription stages. It utilizes elvitegravir as an integrase inhibitor, paired with emtricitabine and tenofovir (TDF) as reverse transcriptase inhibitors. To enable once-daily dosing, it includes cobicistat, a booster that raises elvitegravir levels by inhibiting the CYP3A enzyme.
Form and use:
Stribild combines three active antiviral agents to block HIV replication by targeting the integration and reverse transcription stages. It utilizes elvitegravir as an integrase inhibitor, paired with emtricitabine and tenofovir (TDF) as reverse transcriptase inhibitors. To enable once-daily dosing, it includes cobicistat, a booster that raises elvitegravir levels by inhibiting the CYP3A enzyme.
Generic availability:
As of 2026, there is no generic version of Stribild available in the United States. While its reformulation, Genvoya, is widely used for its reduced impact on kidneys and bones, both are now less common for new treatment starts. Current HIV guidelines generally prefer newer regimens like Biktarvy or dolutegravir-based options due to their superior safety profiles and fewer drug interactions.
Warnings:
Stribild features a boxed warning regarding severe hepatitis B exacerbations if the drug is stopped by co-infected patients, making HBV testing mandatory before initiation. It also carries risks for new or worsening renal impairment and decreased bone mineral density specifically linked to its TDF component. Other concerns include potential lactic acidosis, immune reconstitution syndrome, and extensive drug interactions caused by the booster.
FAQ (Frequently Asked Questions)
How Much Does Stribild Cost Without Insurance?
Stribild costs approximately $3,300–$3,800 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Stribild at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Stribild Different From Genvoya?
Both contain elvitegravir, cobicistat, and emtricitabine. Stribild contains tenofovir disoproxil fumarate (TDF); Genvoya contains tenofovir alafenamide (TAF). TAF achieves the same antiviral activity at lower plasma exposures, with less kidney and bone toxicity. Genvoya was developed as a TAF reformulation of Stribild. Many patients on Stribild have switched to Genvoya, Biktarvy, or a dolutegravir-based regimen for better safety or fewer drug interactions.
Why Does Stribild Need To Be Taken With Food?
Elvitegravir absorption is increased by food. Taking Stribild with food ensures adequate elvitegravir exposure. Skipping food can reduce drug levels and risk virologic failure.
Are There Drug Interactions I Should Know About?
Yes — many. Cobicistat is a strong CYP3A inhibitor. This can raise levels of statins, certain antiarrhythmics, antifungals, anticonvulsants, and many other medications. Some combinations are contraindicated. Always tell every prescriber and pharmacist that you take Stribild.
Can I Get Stribild Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. State ADAP programs may also coordinate with Medicare for HIV-treatment patients.
What If I Have Hepatitis B Co-infection?
Tell your prescriber. Stribild’s FTC and TDF are active against HBV — but if Stribild is ever stopped without other anti-HBV therapy, severe acute HBV flares can occur. HBV testing is required before starting.
What If My Application Is Denied?
If denied, we explore alternatives — switching to Genvoya, Biktarvy, or a dolutegravir-based regimen (each with its own PAP), state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Stribild, our team may be able to help you access assistance programs designed to make brand single-tablet HIV regimens affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.